Cost-effective analysis of clopidogrel versus aspirin for high risk patients with established peripheral arterial disease in China
Z Lin, L Zhang, X Yang, L Liu, J Xuan - Journal of Medical …, 2020 - Taylor & Francis
Objective: To assess the cost-effectiveness of clopidogrel versus aspirin for high risk patients
(pre-existing symptomatic atherosclerosis or multi-vascular territory involvement) with …
(pre-existing symptomatic atherosclerosis or multi-vascular territory involvement) with …
Cost-effective analysis of clopidogrel versus aspirin for high risk patients with established peripheral arterial disease in China.
Z Lin, L Zhang, X Yang, L Liu, J Xuan - Journal of Medical …, 2020 - europepmc.org
Objective: To assess the cost-effectiveness of clopidogrel versus aspirin for high risk patients
(pre-existing symptomatic atherosclerosis or multi-vascular territory involvement) with …
(pre-existing symptomatic atherosclerosis or multi-vascular territory involvement) with …
Cost-effective analysis of clopidogrel versus aspirin for high risk patients with established peripheral arterial disease in China
Z Lin, L Zhang, X Yang, L Liu… - Journal of medical …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective: To assess the cost-effectiveness of clopidogrel versus aspirin for high risk patients
(pre-existing symptomatic atherosclerosis or multi-vascular territory involvement) with …
(pre-existing symptomatic atherosclerosis or multi-vascular territory involvement) with …